Cassava Sciences Inc vs Payoneer Global Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Payoneer Global Inc is far larger — about 50.3× Cassava Sciences Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | PAYO | |
|---|---|---|
Market Cap | $47.75M | $2.40B |
Sector | Health | Technology |
52-Week High | $4.64 | $7.17 |
52-Week Low | $0.87 | $4.27 |
Enterprise Value | -$34.93M | $2.14B |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →